Skip to main content
. Author manuscript; available in PMC: 2015 Dec 31.
Published in final edited form as: Am J Perinatol. 2015 Mar 2;32(10):973–979. doi: 10.1055/s-0035-1545666

Table 2.

Comparison of demographic and perinatal characteristics between infants with and without cPVL on screening imaging

Characteristics All infants < 1,000 g or
< 29 wks without
cPVL, N = 12,075
Cystic PVL with either
CA or PMA
criterion, N = 664
p Value
Birth weight (g), mean ± SD 864 ± 210 855 ± 220 0.29
Gestation (wks), mean ± SD 26.4 ± 1.8 25.9 ± 1.8 < 0.0001a
Male 6,260 (51.9) 327 (49.3) 0.19
Pregnancy-induced hypertension 428 (31.3) 13 (20.6) 0.07
Antepartum hemorrhage 219 (16.0) 15 (23.8) 0.10
Any prenatal steroid 1,236 (10.2) 59 (8.9) 0.26
Complete course of prenatal steroid 977 (79.3) 33 (56.9) < 0.0001a
Maternal antibiotics < 72 h of delivery 923 (92.7) 42 (93.3) 0.99b
Apgar score ≤ 3 at 1 min 11,271 (93.3) 635 (95.6) 0.02a
Apgar score ≤ 3 at 5 min 10,837 (89.8) 613 (92.3) 0.03a
Delivery room bag and mask 1,052 (77.0) 53 (84.1) 0.18
Delivery room chest compression 76 (5.6) 6 (9.5) 0.17
BPD (O2 at 36 wks) 2,424 (47.3) 150 (64.1) < 0.0001a
Steroids for BPD 1,686 (14.1) 118 (17.9) 0.01a
Late-onset culture-proven sepsis 4,009 (33.2) 268 (40.4) 0.0001a
Ventilator days, mean ± SD 23.3 ± 26.7 34.4 ± 30.4 < 0.0001a

Abbreviations: BPD, bronchopulmonary dysplasia; CA, chronological age; cPVL, cystic periventricular leukomalacia; PMA, postmenstrual age; PVL, periventricular leukomalacia; SD, standard deviation.

Note: The percentages are based on nonmissing responses in the registry. The percentages for the complete course of prenatal steroid are among those exposed to any prenatal steroid.

a

Significantly different at an α level of 0.05. Percentages were tested with a chi-square test, and means were tested with a t-test.

b

Tested with Fisher exact test. Values are percent and means; CA criterion: Cranial ultrasound within 28 d, PMA criterion: Screening neuroimaging closest to 36 weeks.